BSP - Biological Signal Processing offers products for the noninvasive diagnosis and monitoring of ischemic heart disease.
The companys HyperQ line of products, which arebased on patented high-frequency technology, offers solutions for both stress ECG tests and resting ECG tests. The HyperQ Stress offers a significant improvement in the diagnosis of patients suspected of having coronary artery disease. The HyperQ Rest provides a tool to enable emergency department teams to detectacute coronary syndrome.
Numerous trials and clinical studies conducted with thousands of patients in Israel, Europe, Asia, and the United Stateshave confirmed the significantly enhanced diagnostic value of the HyperQ technology for the detection of ischemia.
Cumulative Funding Raised Over Time ($)
Employees Over Time
BSP - Biological Signal Processing Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jul 17, 2018
www.itrade.gov.il
BSP Medical coming to India as part of Medical Delegation
#Partners
Dec 22, 2014
www.israel21c.org
HyperQ diagnoses heart disease in the ER
#Customers
Dec 13, 2010
www.prnewswire.com
Biological Signal Processing Ltd. Signs Distribution Agreement in the US With Synergistic Medical Network, LLC